Pleiotropic effects of intravascular haemolysis on vascular homeostasis

British Journal of Haematology

Volumn 148, Issue 5, 2010, Pages 690-701

  Kato, Gregory J ^a,b   Taylor VI, James G ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Haemolysis; Nitric oxide; Sickle cell disease; Thalassaemia; Vasculopathy

Indexed keywords

ARGINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLSERINE; VON WILLEBRAND FACTOR;

ASPLENIA; AUTOIMMUNE HEMOLYTIC ANEMIA; BRAIN VASOSPASM; CONGENITAL DYSERYTHROPOIETIC ANEMIA; DNA MODIFICATION; DYSLIPIDEMIA; ELLIPTOCYTOSIS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME DEFICIENCY; HEREDITARY SPHEROCYTOSIS; HOMEOSTASIS; HUMAN; INTRAVASCULAR HEMOLYSIS; MALARIA; NONHUMAN; OXIDATIVE STRESS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PLEIOTROPY; PRIORITY JOURNAL; PYRUVATE KINASE DEFICIENCY; REVIEW; SICKLE CELL; SUBARACHNOID HEMORRHAGE; THALASSEMIA; THROMBOCYTE ACTIVATION; VASCULAR DISEASE;

ANEMIA, SICKLE CELL; DIABETES MELLITUS; HEMATOLOGIC DISEASES; HEMOLYSIS; HUMANS; INFLAMMATION; NITRIC OXIDE; THALASSEMIA; VASCULAR DISEASES;

EID: 76449093221     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08004.x     Document Type: Review

References (130)

1. Acosta, J., Hettinga, J., Fluckiger, R., Krumrei, N., Goldfine, A., Angarita, L. Halperin, J. (2000) Molecular basis for a link between complement and the vascular complications of diabetes. Proceedings of the National Academy of Sciences of the United States of America, 97, 5450 5455.
2. Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K. Clary, A. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. American Journal of Hematology, 45, 279 282.
3. Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J. Loukopoulos, D. (2001) Cardiac involvement in thalassemia intermedia: a multicenter study. Blood, 97, 3411 3416.
4. Aggeli, C., Antoniades, C., Cosma, C., Chrysohoou, C., Tousoulis, D., Ladis, V., Karageorga, M., Pitsavos, C. Stefanadis, C. (2005) Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. International Journal of Cardiology, 105, 80 84.
5. Aliyu, Z.Y., Gordeuk, V., Sachdev, V., Babadoko, A., Mamman, A.I., Akpanpe, P., Attah, E., Suleiman, Y., Aliyu, N., Yusuf, J., Mendelsohn, L., Kato, G.J. Gladwin, M.T. (2008) Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. American Journal of Hematology, 83, 485 490.
6. Allan, D., Limbrick, A.R., Thomas, P. Westerman, M.P. (1982) Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature, 295, 612 613.
7. Andrieu, V., Dumonceau, O. Grange, M.J. (2003) Priapism in a patient with unstable hemoglobin: hemoglobin Koln. American Journal of Hematology, 74, 73 74.
8. Aslan, M., Ryan, T.M., Adler, B., Townes, T.M., Parks, D.A., Thompson, J.A., Tousson, A., Gladwin, M.T., Patel, R.P., Tarpey, M.M., Batinic-Haberle, I., White, C.R. Freeman, B.A. (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America, 98, 15215 15220.
9. Asleh, R., Marsh, S., Shilkrut, M., Binah, O., Guetta, J., Lejbkowicz, F., Enav, B., Shehadeh, N., Kanter, Y., Lache, O., Cohen, O., Levy, N.S. Levy, A.P. (2003) Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circulation Research, 92, 1193 1200.
10. Asleh, R., Guetta, J., Kalet-Litman, S., Miller-Lotan, R. Levy, A.P. (2005) Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circulation Research, 96, 435 441.
11. Ataga, K.I., Sood, N., De, G.G., Kelly, E., Henderson, A.G., Jones, S., Strayhorn, D., Lail, A., Lieff, S. Orringer, E.P. (2004) Pulmonary hypertension in sickle cell disease. The American Journal of Medicine, 117, 665 669.
12. Ataga, K.I., Moore, C.G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A. Orringer, E.P. (2006) Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. British Journal of Haematology, 134, 109 115.
13. Bensinger, T.A. Gillette, P.N. (1974) Hemolysis in sickle cell disease. Archives of Internal Medicine, 133, 624 631.
14. Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M. Delacourt, C. (2008) G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood, 112, 4314 4317.
15. Bode-Boger, S.M., Scalera, F. Ignarro, L.J. (2007) The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacology and Therapeutics, 114, 295 306.
16. Bordi, B., Rosaria, D.A.M., Guariglia, R., Capobianco, G., Bordi, E. Tirelli, A. (2002) A case of congenital dyserythropoietic anemia type II, Gilbert's syndrome and malleolar trophic ulcers. Hematology, 7, 197 199.
17. Boretti, F.S., Buehler, P.W., D'Agnillo, F., Kluge, K., Glaus, T., Butt, O.I., Jia, Y., Goede, J., Pereira, C.P., Maggiorini, M., Schoedon, G., Alayash, A.I. Schaer, D.J. (2009) Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. Journal of Clinical Investigation, 119, 2271 2280.
18. Brittain, J.E. Parise, L.V. (2008) The alpha4beta1 integrin in sickle cell disease. Transfusion Clinique et Biologique, 15, 19 22.
19. Butthep, P., Rummavas, S., Wisedpanichkij, R., Jindadamrongwech, S., Fucharoen, S. Bunyaratvej, A. (2002) Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. American Journal of Hematology, 70, 100 106.
20. Cappellini, M.D. (2007) Coagulation in the pathophysiology of hemolytic anemias. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2007, 74 78.
21. Cartron, J.P. Elion, J. (2008) Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfusion Clinique et Biologique, 15, 39 50.
22. Cartwright, G.E. (1966) The anemia of chronic disorders. Seminars in Hematology, 3, 351 375.
23. Castro, O., Hoque, M. Brown, B.D. (2003) Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood, 101, 1257 1261.
24. Champion, H.C., Bivalacqua, T.J., Takimoto, E., Kass, D.A. Burnett, A.L. (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proceedings of the National Academy of Sciences of the United States of America, 102, 1661 1666.
25. Chironi, G.N., Boulanger, C.M., Simon, A., Dignat-George, F., Freyssinet, J.M. Tedgui, A. (2009) Endothelial microparticles in diseases. Cell and Tissue Research, 335, 143 151.
26. Chou, R. DeLoughery, T.G. (2001) Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. American Journal of Hematology, 67, 197 199.
27. Crary, S.E. Buchanan, G.R. (2009) Vascular complications after splenectomy for hematologic disorders. Blood, 114, 2861 2868.
28. De Castro, L.M., Jonassaint, J.C., Graham, F.L., Ashley-Koch, A. Telen, M.J. (2008) Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. American Journal of Hematology, 83, 19 25.
29. De Ceulaer, K., Higgs, D.R., Weatherall, D.J., Hayes, R.J., Serjeant, B.E. Serjeant, G.R. (1983) alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease. The New England Journal of Medicine, 309, 189 190.
30. Du, Z.D., Roguin, N., Milgram, E., Saab, K. Koren, A. (1997) Pulmonary hypertension in patients with thalassemia major. American Heart Journal, 134, 532 537.
31. Duits, A.J., Pieters, R.C., Saleh, A.W., van Rosmalen, E., Katerberg, H., Berend, K. Rojer, R.A. (1996) Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clinical Immunology and Immunopathology, 81, 96 98.
32. Edney, M.T., Schned, A.R., Cendron, M., Chaffee, S. Ellsworth, P.I. (2002) Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test). Journal of Urology, 167, 309 310.
33. Eldor, A. Rachmilewitz, E.A. (2002) The hypercoagulable state in thalassemia. Blood, 99, 36 43.
34. Embury, S.H., Dozy, A.M., Miller, J., Davis, Jr., J.R., Kleman, K.M., Preisler, H., Vichinsky, E., Lande, W.N., Lubin, B.H., Kan, Y.W. Mentzer, W.C. (1982) Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. The New England Journal of Medicine, 306, 270 274.
35. Frenette, P.S. (2004) Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation, 11, 167 177.
36. Gladwin, M.T. Vichinsky, E. (2008) Pulmonary complications of sickle cell disease. New England Journal of Medicine, 359, 2254 2265.
37. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886 895.
38. Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J.P., Frangos, J.A., Intaglietta, M. van der Heyde, H.C. (2006) Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nature Medicine, 12, 1417 1422.
39. Grisaru, D., Rachmilewitz, E.A., Mosseri, M., Gotsman, M., Lafair, J.S., Okon, E., Goldfarb, A. Hasin, Y. (1990) Cardiopulmonary assessment in beta-thalassemia major. Chest, 98, 1138 1142.
40. Gyan, E., Darre, S., Jude, B., Cambier, N., Demory, J.L., Bauters, F. Rose, C. (2001) Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy. The Hematology Journal, 2, 210 211.
41. Hagar, R.W., Michlitsch, J.G., Gardner, J., Vichinsky, E.P. Morris, C.R. (2008) Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. British Journal of Haematology, 140, 104 112.
42. Haque, A.K., Gokhale, S., Rampy, B.A., Adegboyega, P., Duarte, A. Saldana, M.J. (2002) Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Human Pathology, 33, 1037 1043.
43. Hayag-Barin, J.E., Smith, R.E. Tucker, Jr., F.C. (1998) Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. American Journal of Hematology, 57, 82 84.
44. Haynes, Jr., J., Obiako, B., King, J.A., Hester, R.B. Ofori-Acquah, S. (2006) Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. American Journal of Physiology. Heart and Circulatory Physiology, 291, H1679 H1685.
45. Hebbel, R.P., Osarogiagbon, R. Kaul, D. (2004) The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation, 11, 129 151.
46. Heller, P.G., Grinberg, A.R., Lencioni, M., Molina, M.M. Roncoroni, A.J. (1992) Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest, 102, 642 643.
47. Herrick, J.B. (1910) Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine, 6, 517 521.
48. Higgs, D.R., Aldridge, B.E., Lamb, J., Clegg, J.B., Weatherall, D.J., Hayes, R.J., Grandison, Y., Lowrie, Y., Mason, K.P., Serjeant, B.E. Serjeant, G.R. (1982) The interaction of alpha-thalassemia and homozygous sickle-cell disease. The New England Journal of Medicine, 306, 1441 1446.
49. Hill, A., Rother, R.P., Wang, X., Morris, S.M. Jr., Quinn-Senger, K., Kelly, R., Richards, S.J., Bessler, M., Bell, L., Hillmen, P. Gladwin, M.T. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, in press.
50. Hobbs, M.R., Udhayakumar, V., Levesque, M.C., Booth, J., Roberts, J.M., Tkachuk, A.N., Pole, A., Coon, H., Kariuki, S., Nahlen, B.L., Mwaikambo, E.D., Lal, A.L., Granger, D.L., Anstey, N.M. Weinberg, J.B. (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet, 360, 1468 1475.
51. Honig, G.R., Telfer, M.C., Rosenblum, B.B. Vida, L.N. (1989) Hb Warsaw (beta 42 Phe - - Val): An unstable hemoglobin with decreased oxygen affinity. I. Hematologic and clinical expression. American Journal of Hematology, 32, 36 41.
52. Hsu, L.L., Miller, S.T., Wright, E., Kutlar, A., McKie, V., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., Elsas, L., Embury, S. Adams, R.J. (2003) Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. Journal of Pediatric Hematology/Oncology, 25, 622 628.
53. Hsu, L.L., Champion, H.C., Campbell-Lee, S.A., Bivalacqua, T.J., Manci, E.A., Diwan, B.A., Schimel, D.M., Cochard, A.E., Wang, X., Schechter, A.N., Noguchi, C.T. Gladwin, M.T. (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood, 109, 3088 3098.
54. Jackson, N., Franklin, I.M. Hughes, M.A. (1986) Recurrent priapism following splenectomy for thalassaemia intermedia. The British Journal of Surgery, 73, 678.
55. Jin, R.C., Voetsch, B. Loscalzo, J. (2005) Endogenous mechanisms of inhibition of platelet function. Microcirculation, 12, 247 258.
56. Kato, G.J. (2009) Haptoglobin halts hemoglobin's havoc. Journal of Clinical Investigation, 119, 2140 2142.
57. Kato, G.J. Gladwin, M.T. (2008) Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. Journal of the American Medical Association, 300, 2638 2646.
58. Kato, G.J., Martyr, S., Blackwelder, W.C., Nichols, J.S., Coles, W.A., Hunter, L.A., Brennan, M.L., Hazen, S.L. Gladwin, M.T. (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. British Journal of Haematology, 130, 943 953.
59. Kato, G.J., Hsieh, M., Machado, R., Taylor, 6th., J., Little, J., Butman, J.A., Lehky, T., Tisdale, J. Gladwin, M.T. (2006) Cerebrovascular disease associated with sickle cell pulmonary hypertension. American Journal of Hematology, 81, 503 510.
60. Kato, G.J., Wang, Z., Machado, R.F., Blackwelder, W.C., Taylor, 6th., J.G. Hazen, S.L. (2009) Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology, 145, 506 513.
61. Kaul, D.K., Liu, X.D., Choong, S., Belcher, J.D., Vercellotti, G.M. Hebbel, R.P. (2004) Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. American Journal of Physiology. Heart and Circulatory Physiology, 287, H293 H301.
62. Kaul, D.K., Liu, X.D., Zhang, X., Ma, L., Hsia, C.J. Nagel, R.L. (2006) Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants. American Journal of Physiology. Heart and Circulatory Physiology, 291, H167 H175.
63. Kim, B.J., Park, K.W., Koh, S.B., Kim, H.K., Jung, H.L., Park, M.K. Lee, D.H. (2005) Stroke induced by splenectomy in hemoglobin Madrid: autopsy clues to the underlying mechanism. Blood Coagulation and Fibrinolysis, 16, 141 144.
64. Koshy, M., Entsuah, R., Koranda, A., Kraus, A.P., Johnson, R., Bellvue, R., Flournoy-Gill, Z. Levy, P. (1989) Leg ulcers in patients with sickle cell disease. Blood, 74, 1403 1408.
65. Krishnan, K., Martinez, F., Wille, R.T., Jones, R.T., Shih, D.T., Head, C., Fairbanks, V.F. Dabich, L. (1994) Hb Washtenaw [beta 11(A8)Val - >Phe]: an electrophorectically silent, unstable, low oxygen affinity variant associated with anemia and chronic cyanosis. Hemoglobin, 18, 285 295.
66. Landburg, P.P., Teerlink, T., Muskiet, F.A., Duits, A.J. Schnog, J.J. (2008) Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis. American Journal of Hematology, 83, 577 579.
67. Lee, F.S. (2008) Genetic causes of erythrocytosis and the oxygen-sensing pathway. Blood Reviews, 22, 321 332.
68. Lee, M.T., Rosenzweig, E.B. Cairo, M.S. (2007) Pulmonary hypertension in sickle cell disease. Clinical Advances in Hematology & Oncology, 5, 645 653.
69. Levy, A.P., Hochberg, I., Jablonski, K., Resnick, H.E., Lee, E.T., Best, L. Howard, B.V. (2002) Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study. Journal of the American College of Cardiology, 40, 1984 1990.
70. Liem, R.I., Nevin, M.A., Prestridge, A., Young, L.T. Thompson, A.A. (2009) Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease. Pediatric Pulmonology, 44, 281 289.
71. Lode, H.N., Krings, G., Schulze-Neick, I., Dahmlow, S., Schroeder, U., Bonnet, R., Dapalma, J., Luck, W., Strau, G., Berger, F. Gaedicke, G. (2007) Pulmonary Hypertension in a Case of Hb-Mainz Hemolytic Anemia. Journal of Pediatric Hematology/Oncology, 29, 173 177.
72. Lopansri, B.K., Anstey, N.M., Weinberg, J.B., Stoddard, G.J., Hobbs, M.R., Levesque, M.C., Mwaikambo, E.D. Granger, D.L. (2003) Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet, 361, 676 678.
73. Minniti, C.P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N., Onyekwere, O., Nouraie, M., Kato, G.J., Gladwin, M.T., Castro, O.L. Gordeuk, V.R. (2009) Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica, 94, 340 347.
74. Montalban, J., Lozano, P., Lu, L. Gonzalez, A. (1986) [Paroxysmal nocturnal hemoglobinuria and priapism]. Medicina Clínica, 87, 394.
75. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr., S.M. Gladwin, M.T. (2005a) Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension and Mortality in Sickle Cell Disease. Journal of the American Medical Association, 294, 81 90.
76. Morris, C.R., Kuypers, F.A., Kato, G.J., Lavrisha, L., Larkin, S., Singer, T. Vichinsky, E.P. (2005b) Hemolysis-associated pulmonary hypertension in thalassemia. Annals of the New York Academy of Sciences, 1054, 481 485.
77. Morris, C.R., Suh, J.H., Hagar, W., Larkin, S., Bland, D.A., Steinberg, M.H., Vichinsky, E.P., Shigenaga, M., Ames, B., Kuypers, F.A. Klings, E.S. (2008) Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood, 111, 402 410.
78. Muller-Soyano, A., Tovar de Roura, E., Duke, P.R., De Acquatella, G.C., Arends, T., Guinto, E. Beutler, E. (1976) Pyruvate kinase deficiency and leg ulcers. Blood, 47, 807 813.
79. Nelson, S.C., Adade, B.B., McDonough, E.A., Moquist, K.L. Hennessy, J.M. (2007) High prevalence of pulmonary hypertension in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 29, 334 337.
80. Neonato, M.G., Guilloud-Bataille, M., Beauvais, P., Begue, P., Belloy, M., Benkerrou, M., Ducrocq, R., Maier-Redelsperger, M., De Montalembert, M., Quinet, B., Elion, J., Feingold, J. Girot, R. (2000) Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. European Journal of Haematology, 65, 155 164.
81. Nolan, V.G., Wyszynski, D.F., Farrer, L.A. Steinberg, M.H. (2005a) Hemolysis-associated priapism in sickle cell disease. Blood, 106, 3264 3267.
82. Nolan, V.G., Baldwin, C., Ma, Q., Wyszynski, D.F., Amirault, Y., Farrell, J.J., Bisbee, A., Embury, S.H., Farrer, L.A. Steinberg, M.H. (2005b) Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. British Journal of Haematology, 128, 266 272.
83. Nolan, V.G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D.F., Farrell, J.J., Sebastiani, P., Farrer, L.A. Steinberg, M.H. (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. British Journal of Haematology, 133, 570 578.
84. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288 294.
85. Onyekwere, O.C., Campbell, A., Teshome, M., Onyeagoro, S., Sylvan, C., Akintilo, A., Hutchinson, S., Ensing, G., Gaskin, P., Kato, G., Rana, S., Kwagyan, J., Gordeuk, V., Williams, J. Castro, O. (2008) Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatric Cardiology, 29, 309 312.
86. Pashankar, F.D., Carbonella, J., Bazzy-Asaad, A. Friedman, A. (2008) Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics, 121, 777 782.
87. Pavlovic, S., Kuzmanovic, M., Urosevic, J., Poznanic, J., Zoranovic, T., Djordjevic, V., Rasovic, N., Bunjevacki, G., Cvorkov-Drazic, M. Colovic, M. (2004) Severe central nervous system thrombotic events in hemoglobin Sabine patient. European Journal of Haematology, 72, 67 70.
88. Pluta, R.M., Dejam, A., Grimes, G., Gladwin, M.T. Oldfield, E.H. (2005) Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of the American Medical Association, 293, 1477 1484.
89. Pluta, R.M., Hansen-Schwartz, J., Dreier, J., Vajkoczy, P., Macdonald, R.L., Nishizawa, S., Kasuya, H., Wellman, G., Keller, E., Zauner, A., Dorsch, N., Clark, J., Ono, S., Kiris, T., Leroux, P. Zhang, J.H. (2009) Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurological Research, 31, 151 158.
90. Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, III., R.O., Schechter, A.N. Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 1383 1389.
91. Rother, R.P., Bell, L., Hillmen, P. Gladwin, M.T. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Journal of the American Medical Association, 293, 1653 1662.
92. Rothman, S.M., Fulling, K.H. Nelson, J.S. (1986) Sickle cell anemia and central nervous system infarction: a neuropathological study. Annals of Neurology, 20, 684 690.
93. Ruf, A., Pick, M., Deutsch, V., Patscheke, H., Goldfarb, A., Rachmilewitz, E.A., Guillin, M.C. Eldor, A. (1997) In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. British Journal of Haematology, 98, 51 56.
94. Sadler, J.E. (2008) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood, 112, 11 18.
95. Scalera, F., Kielstein, J.T., Martens-Lobenhoffer, J., Postel, S.C., Tager, M. Bode-Boger, S.M. (2005) Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase. Journal of the American Society of Nephrology, 16, 892 898.
96. Schaer, D.J., Alayash, A.I. Buehler, P.W. (2007) Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxidants Redox Signaling, 9, 991 999.
97. Schafer, A., Wiesmann, F., Neubauer, S., Eigenthaler, M., Bauersachs, J. Channon, K.M. (2004) Rapid regulation of platelet activation in vivo by nitric oxide. Circulation, 109, 1819 1822.
98. Schilling, R.F., Gangnon, R.E. Traver, M.I. (2008) Delayed adverse vascular events after splenectomy in hereditary spherocytosis. Journal of Thrombosis and Haemostasis, 6, 1289 1295.
99. Schnog, J.B., Rojer, R.A., Mac Gillavry, M.R., ten Cate, H., Brandjes, D.P. Duits, A.J. (2003) Steady-state sVCAM-1 serum levels in adults with sickle cell disease. Annals of Hematology, 82, 109 113.
100. Schnog, J.B., Teerlink, T., van der Dijs, F.P., Duits, A.J. Muskiet, F.A. (2005) Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. Annals of Hematology, 84, 282 286.
101. Schnog, J.J., Hovinga, J.A., Krieg, S., Akin, S., Lammle, B., Brandjes, D.P., Mac Gillavry, M.R., Muskiet, F.D. Duits, A.J. (2006) ADAMTS13 activity in sickle cell disease. American Journal of Hematology, 81, 492 498.
102. Sedrak, A., Rao, S.P., Miller, S.T., Hekmat, V. Rao, M. (2009) A prospective appraisal of pulmonary hypertension in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 31, 97 100.
103. Setty, B.N. Betal, S.G. (2008) Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood, 111, 905 914.
104. Setty, B.N., Kulkarni, S. Stuart, M.J. (2002) Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood, 99, 1564 1571.
105. Setty, B.N., Stuart, M.J., Dampier, C., Brodecki, D. Allen, J.L. (2003) Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet, 362, 1450 1455.
106. Shet, A.S., Aras, O., Gupta, K., Hass, M.J., Rausch, D.J., Saba, N., Koopmeiners, L., Key, N.S. Hebbel, R.P. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood, 102, 2678 2683.
107. Singer, S.T. Ataga, K.I. (2008) Hypercoagulability in sickle cell disease and beta-thalassemia. Current Molecular Medicine, 8, 639 645.
108. Singer, S.T., Kuypers, F.A., Styles, L., Vichinsky, E.P., Foote, D. Rosenfeld, H. (2006) Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. American Journal of Hematology, 81, 670 675.
109. Solovey, A., Gui, L., Key, N.S. Hebbel, R.P. (1998) Tissue factor expression by endothelial cells in sickle cell anemia. The Journal Of Clinical Investigation, 101, 1899 1904. (Pubitemid 28226109)
110. Steinberg, M.H., Rosenstock, W., Coleman, M.B., Adams, J.G., Platica, O., Cedeno, M., Rieder, R.F., Wilson, J.T., Milner, P. West, S. (1984) Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood, 63, 1353 1360.
111. Stevens, D.M., Shupack, J.L., Javid, J. Silber, R. (1977) Ulcers of the leg in thalassemia. Archives of Dermatology, 113, 1558 1560.
112. Strijbos, M.H., Landburg, P.P., Nur, E., Teerlink, T., Leebeek, F.W., Rijneveld, A.W., Biemond, B.J., Sleijfer, S., Gratama, J.W., Duits, A.J. Schnog, J.J. (2009) Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells, Molecules, and Diseases, 43, 63 67.
113. Taher, A., Abou-Mourad, Y., Abchee, A., Zalouaa, P. Shamseddine, A. (2002) Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin, 26, 107 112.
114. Taher, A.T., Otrock, Z.K., Uthman, I. Cappellini, M.D. (2008) Thalassemia and hypercoagulability. Blood Reviews, 22, 283 292.
115. Thuret, I., Bardakdjian, J., Badens, C., Wajcman, H., Galacteros, F., Vanuxem, D., Perrimond, H., Giraud, F. Lena-Russo, D. (1996) Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted beta 141 (H19) Leu - >Arg. American Journal of Hematology, 51, 133 136.
116. Vanscheidt, W., Leder, O., Vanscheidt, E., Wokalek, H., Wilmer, J., Hofmann, E. Schopf, E. (1990) Leg ulcers in a patient with spherocytosis: a clinicopathological report. Dermatologica, 181, 56 59.
117. Verhamme, P. Hoylaerts, M.F. (2006) The pivotal role of the endothelium in haemostasis and thrombosis. Acta Clinica Belgica, 61, 213 219.
118. Villagra, J., Shiva, S., Hunter, L.A., Machado, R.F., Gladwin, M.T. Kato, G.J. (2007) Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension and nitric oxide scavenging by cell-free hemoglobin. Blood, 110, 2166 2172.
119. Voskaridou, E., Tsetsos, G., Tsoutsias, A., Spyropoulou, E., Christoulas, D. Terpos, E. (2007) Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica, 92, 738 743.
120. Westerman, M., Pizzey, A., Hirschman, J., Cerino, M., Weil-Weiner, Y., Ramotar, P., Eze, A., Lawrie, A., Purdy, G., Mackie, I. Porter, J. (2008) Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. British Journal of Haematology, 142, 126 135.
121. Westwick, J., Watson-Williams, E.J., Krishnamurthi, S., Marks, G., Ellis, V., Scully, M.F., White, J.M. Kakkar, V.V. (1983) Platelet activation during steady state sickle cell disease. Journal of Medicine, 14, 17 36.
122. Wood, K.C., Hebbel, R.P. Granger, D.N. (2005) Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB Journal, 19, 989 991.
123. Wun, T., Paglieroni, T., Rangaswami, A., Franklin, P.H., Welborn, J., Cheung, A. Tablin, F. (1998) Platelet activation in patients with sickle cell disease. British Journal of Haematology, 100, 741 749.
124. Yater, W.M. Hansmann, G.H. (1936) Sickle-cell anemia: A new cause of cor pulmonale: report of two cases with Numerous disseminated occlusions of the small pulmonary arteries. American Journal of the Medical Sciences, 191, 474 484.
125. Yeo, T.W., Lampah, D.A., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y.R., Darcy, C.J., Granger, D.L., Weinberg, J.B., Lopansri, B.K., Price, R.N., Duffull, S.B., Celermajer, D.S. Anstey, N.M. (2007) Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. Journal of Experimental Medicine, 204, 2693 2704.
126. Yuditskaya, S., Tumblin, A., Hoehn, G.T., Wang, G., Drake, S.K., Xu, X., Ying, S., Chi, A.H., Remaley, A.T., Shen, R.F., Munson, P.J., Suffredini, A.F. Kato, G.J. (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood, 113, 1122 1128.
127. Yuhanna, I.S., Zhu, Y., Cox, B.E., Hahner, L.D., Osborne-Lawrence, S., Lu, P., Marcel, Y.L., Anderson, R.G., Mendelsohn, M.E., Hobbs, H.H. Shaul, P.W. (2001) High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nature Medicine, 7, 853 857.
128. Zennadi, R., De Castro, L., Eyler, C., Xu, K., Ko, M. Telen, M.J. (2008) Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors. Transfusion Clinique et Biologique, 15, 23 28.
129. Zhang, Y., Qui, Y., Zhu, J. Gao, D. (2007) Pulmonary hypertension associated with autoimmune hemolytic anemia: a case report. International Journal of Cardiology, 115, e1 e2.
130. Zhou, Z., Han, H., Cruz, M.A., Lopez, J.A., Dong, J.F. Guchhait, P. (2009) Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thrombosis and Haemostasis, 101, 1070 1077.